Similar articles for PMID: 80421

Year	Number of Results
1974	1
1975	2
1976	6
1977	11
1978	12
1979	13
1980	14
1981	8
1982	12
1983	6
1984	3
1985	5
1986	5
1987	1
1989	1
1990	1
2022	0

1

Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. IV. Correlation between the loss of cell surface trinitrophenyl-H-2 molecules and functional activity of derivatized cells in an anti-TNP-CML assay.

Forman J, Vitetta ES. Forman J, et al. J Immunol. 1978 Sep;121(3):1002-6. J Immunol. 1978. PMID: 80421 Free PMC article.

2

Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulfonic acid.

Vitetta ES, Hart DA, Forman J. Vitetta ES, et al. J Immunol. 1978 Sep;121(3):997-1001. J Immunol. 1978. PMID: 690447

3

Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. I. H-2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized.

Forman J, Vitetta ES, Hart DA, Klein J. Forman J, et al. J Immunol. 1977 Mar;118(3):797-802. J Immunol. 1977. PMID: 66272

4

T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.

Forman J. Forman J. J Immunol. 1977 May;118(5):1755-62. J Immunol. 1977. PMID: 404357

5

Relationship between trinitrophenyl and H-2 antigens on trinitrophenyl-modified spleen cells. II. Correlation between derivatization of H-2 antigens with trinitrophenyl and the ability of trinitrophenyl-modified cells to react functionally to the CML assay.

Forman J, Vitetta ES, Hart DA. Forman J, et al. J Immunol. 1977 Mar;118(3):803-8. J Immunol. 1977. PMID: 66273

6

Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface-bound trinitrophenyl dextran.

Henkart PA, Schmitt-Verhulst M, Shearer GM. Henkart PA, et al. J Exp Med. 1977 Oct 1;146(4):1068-78. doi: 10.1084/jem.146.4.1068. J Exp Med. 1977. PMID: 70501 Free PMC article.

7

Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.

Burakoff SJ, Germain RN, Benacerraf B. Burakoff SJ, et al. J Exp Med. 1976 Dec 1;144(6):1609-20. doi: 10.1084/jem.144.6.1609. J Exp Med. 1976. PMID: 1087327 Free PMC article.

8

T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.

Miller SD, Butler LD, Cleveland RP, Moorhead JW, Claman HN, Chiller JC. Miller SD, et al. Cell Immunol. 1983 Dec;82(2):378-93. doi: 10.1016/0008-8749(83)90171-5. Cell Immunol. 1983. PMID: 6197193

9

On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.

Forman J. Forman J. J Exp Med. 1975 Aug 1;142(2):403-18. doi: 10.1084/jem.142.2.403. J Exp Med. 1975. PMID: 1079848 Free PMC article.

10

The secondary cytotoxic response to trinitrophenyl (TNP) modified syngeneic lymphocytes: effectors generated in vitro differ from those generated in vivo.

Tagart V. Tagart V. Scand J Immunol. 1978;8(2):91-7. doi: 10.1111/j.1365-3083.1978.tb00500.x. Scand J Immunol. 1978. PMID: 705261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed